Fonar has notified other vendors of its claimsFonar's assertion of MR patent claims is threatening to expandinto a legal imbroglio involving the entire MR industry. SiemensMedical Systems became the latest vendor to be dragged into
Fonar's assertion of MR patent claims is threatening to expandinto a legal imbroglio involving the entire MR industry. SiemensMedical Systems became the latest vendor to be dragged into thecontroversy when it filed a federal lawsuit last week seekingto have Fonar's patent claims declared invalid. Siemens will probablynot be the last vendor to take such action, as Fonar has notifiedother MR manufacturers that it considers their products to beinfringing on its patents.
Fonar, of Melville, NY, began the dispute in 1992 when it filedsuit against GE Medical Systems, Hitachi Ltd. and two imagingcenters. It claimed that the defendants were infringing on fourbasic MR patents invented by Fonar founder Raymond Damadian. Theyinclude the world's first MR patent, entitled "Apparatusand method for detecting cancer in tissue," and a patentfor multi-angle-oblique MRI.
Fonar settled with Hitachi last month in an agreement thatincluded an unspecified cash payment to Fonar (SCAN 4/26/95).Fonar has gone forward with its lawsuit against GE and is claiming$300 million in damages.
Fonar believes its patents are broad and the company has notifiedother MR vendors that it believes they are infringing, accordingto Fonar counsel Ronald Schutz of Robins, Kaplan, Miller and Ciresiof Minneapolis. Siemens was one of those companies, and last weekthe Iselin, NJ, vendor filed suit in U.S. District Court in Wilmington,DE, asking that Fonar's patents be declared invalid and/or thatSiemens be declared not in violation of the patents. Siemens didnot sue Fonar on any of Siemens' patents.
"Fonar had not begun any substantial legal activitiesagainst Siemens regarding its MRI patents," a Fonar spokespersonsaid. "This indicates that Siemens believes it is now vulnerableand that it will also be sued for patent infringement by Fonaror it wouldn't have responded with this defensive action."
Siemens executives were not available for comment. Fonar hasnot yet decided how to respond to Siemens' lawsuit, accordingto Schutz.
Fonar's jury trial against GE began April 25. The trial hasbeen bifurcated, with a liability trial taking place first, tobe followed by a damages trial if necessary, Schutz said. Thetrial's first week featured Damadian taking the witness standfor two days. He testified on the multi-angle-oblique patent andprovided general background information about Fonar.
The trial adjourned for the week of May 1 due to a conflictin the judge's schedule, Schutz said. The trial was scheduledto resume May 8 with GE's cross-examination of Fonar employeeBob Wolf, one of the inventors of the multi-angle-oblique patent.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).